Mesenchymal epithelial transition factor (MET) is one of the critical cell signaling molecules whose aberrant expression is reported in several human cancers. The aim of the study is to investigate the antigene and antiproliferative effect of short triplex forming oligonucleotides, TFO-1 (part of the positive regulatory element) and TFO-2 (away from the transcription start site) on MET expression. HepG2 cells transfected only with TFO-1 (but not with TFO-2 and non-specific TFO) significantly decreased MET levels, which is accompanied by decrease in antiapoptotic proteins and increase in pro-apoptotic proteins. Phosphoproteome-array analysis of 46 intracellular kinases revealed hypophosphorylation of about 15 kinases including ERK, AKT, Src and MEK, suggesting the growth inhibitory effect of TFO-1. Further, the efficacy of TFO-1 was tested on diethylnitrosamine-induced liver tumors in wistar rats. T2-weighted magnetic resonance imaging showed decrease in liver tumor volume up to 90% after treatment with TFO-1. Decreased MET expression and elevated apoptotic activity further indicate that TFO-1 targeted to c-met leads to cell death and tumor regression in hepatoma. Formation of stable DNA triplex between TFO-1 and targeted gene sequence was confirmed by circular dichroic spectroscopy and gel retardation assay. Therefore, it can be concluded that DNA triplex-based therapeutic approaches hold promise in the treatment of malignancies associated with MET overexpression.
Introduction
The c-met gene encodes a receptor tyrosine kinase, called hepatocyte growth factor receptor, also commonly referred as mesenchymal epithelial transition factor (MET). 1 MET/hepatocyte growth factor signaling has a crucial role in a variety of cellular functions during normal cell growth. 2 However, aberrant signaling of MET is frequently associated with cell scattering, angiogenesis, proliferation, enhanced motility, invasion and eventually metastasis. 3 Several clinical studies have shown the relationship between overexpression of MET with the aggressive nature of tumors and poor therapeutic response. The constitutive activation of MET in cancers has been ascribed to (i) primarily overexpression of MET being the most frequent mechanism in various solid tumors such as hepatocellular carcinoma (HCC), 4 biliary tract carcinomas 5 and lung cancer 6 , (ii) the formation of autocrine loops between MET and its ligand, hepatocyte growth factor causing uncontrolled cell signaling like osteosarcoma 7 and breast cancer 8 and (iii) the activation of point mutations in the tyrosine kinase region of MET which is although less frequent as reported in sporadic papillary renal cancer, 9 gastric cancer 10 and so on. Engelman et al., 6 showed that MET amplification led to the gefitinib (inhibitor of epidermal growth factor receptor) resistance in non-small cell lung cancer cell line via activation of PI3K signaling. This clearly generated a lot of interest in MET and therapies. 11, 12 Therapies targeted against MET have been widely anticipated as a potential antitumor strategy. Therefore, keeping in view of the crucial role of MET in cancer, the primary interest in developing therapeutics is either to downregulate the (over) expression of MET or to inhibit the functional activity of MET. A number of small molecules which are competitors of ATP binding site and target intracellular kinase domain of the MET receptor thereby block the kinase activity like PHA-665752, be partially toxic and non-specific in nature. Therefore, antigene-or antisense-based technologies pose themselves as most specific approach in comparison with them. There are several ways by which antigene therapy have been attempted in context to c-met in variety of cancers in cell lines 18, 19 and in animal models. 20 However, to the best of our knowledge, there are no reports on targeting c-met by triplex forming oligonucleotide (TFO)-based antigene therapy. However, DNA triplex-based antigene approach on various proto-oncogenes like c-myc, 21 ki-ras, 22 bcl-2, 23 and her-2 24 is being investigated. The focus of the present study is to investigate the antitumorigenic activity of specific TFOs targeted against the promoter part of c-met in hepatoma both in vitro in HepG2 cell line and in vivo using rat model of HCC. Results provide relevant direction toward designing of TFOs as a potential therapeutic alternative in malignancies with MET involvement.
Materials and methods

Designing of TFOs
The schematic structure of c-met promoter and the sequences of the triplex target sites are shown in Figure 1a . The sequences of the used oligonucleotides were TFO-1 (5 0 -AGGAGGGGGGAGAGG-3 0 ) and TFO-2 (5 0 -AAGAAAAAAAGAAAAAAAAAAAG-3 0 ), respectively. TFO-3 (5 0 -AGAAGAGAGGGGGGG-3 0 ), the control had the same length with five mismatched nucleotides (one base per codon) at different positions of TFO-1.
All the oligonucleotides were purchased from Integrated DNA Technology (Coralville, IA). The oligonucleotides were dissolved in DNase-and RNase-free water and aliquots were kept at À20 1C until use. For the circular dichroic spectroscopy and gel retardation assay (GRA), the concentrations of the oligonucleotides were estimated using molar extinction coefficient at e 260 of 254 680, 193 860 and 173190 M À1 cm
À1
, respectively, for
0 . The molar extinction coefficients were calculated using nearest neighbor analysis of the unfolded species. 25 It is possible that an oligonucleotide in solution can alone form self-structures like hairpins or triplexes or tetraplexes. To rule out the possibility of existence of such intramolecular or interstranded ordered structures in solution, UV melting experiments were carried out. No hyperchromicity was observed for any of the oligonucleotides and this is an indication of the presence of a linear unfolded oligonucleotide entity in solution.
Reagents and antibodies Dulbecco's Modified Eagle's medium, fetal calf serum, trypsin-EDTA, penicillin G, streptomycin and amphotericin B were from GIBCO BRL (Gaithers-burg, MD 
Human phospho-intracellular kinase array
The phospho-kinase array was used to detect the relative phosphorylation of 46 different intracellular signaling molecules, captured on nitrocellulose membrane. Array (Array 003) was obtained from R&D Systems (Foster City, CA) and was used according to the manufacturer's instructions. Briefly, arrays were incubated overnight with a total 1000 mg of cell lysates followed by washing. Phosphorylation status of cell proteome was evaluated by incubating the membranes in a pool of provided conjugated antibodies and then by chemiluminescence. Intensity of each spot detected with phospho-kinase array was measured by Image J software (National Institutes of Health, Bethesda, MD) and calculated for the relative intensity of the average signal of the pair of duplicated spots to the negative control spots. Background intensity was also determined and subtracted from each average signal.
Schedule of liver tumor induction and TFO-1 treatment in wistar rats Random bred 6-8-week-old male wistar rats (100-150 g) were obtained and maintained in the experimental animal facility of All India Institute of Medical Sciences with food and water ad libitum. Animals were handled according to Animal Ethical Committee guidelines for the care of laboratory animals (Project clearance no. 373/ Institutional Animal Ethical Committee/06). Animals were divided into three groups, that is, normal, control and test groups. Liver tumors were induced in the control and test groups by oral administration of diethylnitrosamine (DEN) (Sigma, St Louis, MO) in drinking water (40 p.p.m.) up to 8 weeks. Water bottles were protected from light and fresh solutions of DEN were prepared every day. Control group was given the free liposomes, that is, without encapsulation of TFO. Test group was subdivided into two groups, group I (2 weeks) and group II (5 weeks) and treated with liposomes encapsulated with TFO-1 (4 mg kg À1 body weight, i.p.). Formation of liposomes was confirmed by Transmission Electron Microscopic imaging (data not shown).
Monitoring of tumor volume by magnetic resonance imaging analysis
Magnetic resonance (MR) experiments were carried out using 4.7 T scanner (BIOSPEC Bruker BioSpin MRI GmbH, Ettlingen, Germany) using a 72-mm resonator as transmitter/receiver coil. The animals were placed with the upper abdomen area centered on the surface coil of the equipment. Animals were anesthetized using chloral hydrate (400 mg kg À1 body weight, i.p.) and their body temperature was constantly maintained using a circulating warm water bath attached to the animal bed. Following the scout scan in all three planes, T2-weighted (T2-W) images were acquired using RARE sequence in axial plane using the following parameters: retention time/echo delay time ¼ 3000/56 ms, RARE factor ¼ 8, slice thickness ¼ 2 mm, interslice distance ¼ 2 mm, averages ¼ 4 and matrix size ¼ 256 Â 256.
Histopathological and immunohistochemical analysis
After evaluation of tumor by magnetic resonance imaging (MRI), animals were sacrificed by approved euthanasia techniques according to Institutional Animal Ethical Committee guidelines under aseptic conditions. Histopathological analysis and immunohistochemistry were performed as described previously. 26 In negative controls, the primary antibody was replaced by non-immune IgG of the same isotype to ensure specificity. Image analysis was done using Nikon microscope (Otawara, Tochigi, Japan).
Protein extraction and western blotting
Total cell protein was extracted from the liver tissue using a lysis buffer (50 mmol l À1 Tris-HCl (pH 8.0), 1% Triton X-100, 0.1% sodium dodecyl sulfate, 250 mmol l À1 NaCl and 5 mmol l À1 phenylmethanesulfonylfluoride, 5 mg ml À1 pepstatin and 5 mg ml À1 leupeptin). Tissue sample was cut and minsed in lysis buffer followed by homogenization and centrifugation at 12 000 r.p.m. for 30 min. All the procedures were performed at 4 1C. Western blot for the MET protein was performed according to the above-described protocol. 25 
Measurement of apoptosis
Apoptosis was determined by TUNEL assay using Fluorescein FragEL DNA fragmentation detection kit from Calbiochem (San Diego, CA) (Catalog no. QIA39) according to the manufacturer's instructions.
Circular dichroism spectroscopy
Circular dichroism (CD) experiments were carried out using a JASCO-810 spectropolarimeter (Jasco International, Tokyo, Japan) equipped with in-built peltier controlled thermostat cell holder (PTC-423S) and data processor. The melting profile and isothermal CD spectrum were acquired as described previously. 25 Gel retardation assay For GRA, the pyrimidine strand of DNA-1 duplex and TFO-1 was 5 0 end labeled with g-32 P [ATP] by T4 polynucleotide kinase using standard protocol. 27 The triplex was obtained by mixing 50 nM each of the DNA-1 (with labeled pyrimidine strand) and cold TFO-1 in 10 mM sodium cacodylate buffer containing 10 mM NaCl, pH 7.4. The assay was performed as per our earlier method. 28 
Statistical analysis
Body weight, apoptotic index, immunostaining scores and quantitative densitometry values were analyzed by the unpaired Student's t-test (SPSS statistical analysis software, version 10.0, IBM SPSS, Chicago, IL). Po0.05 was considered statistically significant. Values were expressed as mean values ± s.d. as indicated.
Results
The positive regulatory element of c-met gene contains a 155-bp long (-223 to À68) sequence which is proven to be important for transcriptional regulation. 29 Promoter sequence analysis have a very high degree of sequence homology (B90%) between human and rat c-met gene. 30 Based on our experience on c-myc, hmg, frataxin and so on, two possible triplex targeted sequences (TTSs) were selected for the present study after thorough screening of c-met promoter, and by considering all the prerequisites for the DNA triplex formation (Figure 1a) . 31 TTS-1 is located at À144 to À119 (within the positive regulatory element) while TTS-2 is situated at À644 to À620, which is slightly away from transcription start site. TFO-3 has been included in the study for checking the non-specific interaction and inhibiton of MET. Sequence specificity of TFOs was also confirmed by BLAST.
TFO mediated cell growth inhibition of HepG2 cells
To increase the resistance toward exogenous and endogenous nucleases, the triplex forming oligonucleotides were phosphorothioated in their sugar-phosphate backbones. Figure 1b shows the cell viability of HepG2 cells in the presence of different TFOs in a dose-dependent manner. It can be seen that TFO-1 was the most effective inhibitor of cell proliferation as the number of viable cells reduced by 50% even at a very low concentration of 10 nM while the growth was inhibited by 85% at 1 mM. No detectable cell inhibition was observed in the cells treated with TFO-2 and TFO-3.
Reduction of endogenous MET expression in response to TFO-1 Figure 2a shows the protein expression pattern of phospho and basal levels of MET in HepG2 cells in the presence of TFO-1. Three dosages 10, 100 nM and 1 mM for the TFO-1 were selected depending upon its inhibitory concentrations. Basal levels of MET protein were found to be reduced by 25% and phosphorylation was almost undetectable after 72 h treatment of TFO-1 at 10 nM. At concentrations 100 nM and 1 mM of TFO-1, the basal levels of MET were reduced 450%. Figure 2c shows the fold intensity change in the MET levels. In contrast to TFO-1, other two TFOs did not show any inhibition on MET protein expression (data not shown).
Effect of TFO-1 on pro-apoptotic and antiapoptotic proteins Western blot analysis of some pro-apoptotic and antiapoptotic proteins is shown in Figure 2b . Hyperphosphorylation of p53 under TFO-1 treatment was observed, while endogenous levels of p53 remian unaffected. Similary, basal levels of c-myc were also unchanged while the phosphorylated status was reduced. Bax protein was found to be increased while Bcl-xl was decrased after initial treatment of TFO-1. Figure 2c shows the fold change in the intensities of the western blots.
Intracellular signaling kinase array
To determine the effect of MET knockdown on key signaling pathways, an intracellular signaling kinase array was performed. A representative map of kinase array is providing the alignment of the kinases on the membrane and is shown in Figure 3c Figure 3d ). In contrast to these molecules, phosphorylation status of some kinases was elevated like p53, Chk-2 and Stats (indicated by numbers in J, Figure 3e ). Kinases whose phosphorylation levels were undetectable in both the conditions were excluded.
The biological activity of the TFO-1 on the growth of human HCC cells was also accompanied by evaluating them in vivo. Oral administration of DEN induced HCC in wistar rats and animals were measured for body and liver weight during the complete course of the study. Tumorigenesis caused increase in the liver weight of animals in comparison with the normal conditions as shown in Figure 4c . When animals were subjected to TFO-1, a decrease in the liver weight was observed while body weight was not grossly effected. Overall appearance of the animals was also improved which was accompanied with 100% survival rate in the test group in comparison with the control group.
MRI analysis of animals MRI examination proves to be a useful technique not only for detection of rat liver tumors, but also for the study of their dynamic growth. Figure 4a shows T2-weighted MR images of rat liver from normal, control and TFO-1-treated test groups. MR examination of normal group of rats showed no visible changes in the liver with time (Figure 4a , upper panel i-iii). Middle panel in Figure 4a (iv-vi) shows control group where both tumor size and intensity increase with time, that is, 16 (group 0), 18 (16 þ 2, group I) and 21 (16 þ 5, group II) weeks of tumor progression, respectively. On contrary, the lower panel in Figure 4a (vii-ix) which is of the test group shows the decrease in both the tumor size as well as 
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the intensity with respect to the above-mentioned time points. Figure 4b represents the calculated liver tumor volumes at all the mentioned stages. MRI unveiled the most interesting finding that in test group tumor volumes decreased by 80% after 2 weeks and 490% after 5 weeks of TFO-1 treatment.
Histopathological analysis and TUNEL assay
Further, the observations made by MRI were correlated with the histological findings. The same animals were sacrificed and histopathological examination was done (Figure 5a ). The biopsy of the normal rat showed hepatocytes that are within the normal histological limits (Figure 5ai ). The rat liver from the control group showed histological features of poorly differentiated HCCs (Figure 5aii ) like tumor cells show marked nuclear polymorphism with prominent nucleoli, atypical mitotic figures and moderate amount of cytoplasm. The histological features of the TFO-1-treated test group I showed a group of few apoptotic bodies along with individual cell necrosis ( Figure 5aiii ). As the TFO-1 treatment continued till 5 weeks, in test group II, increase in apoptotic bodies was observed on microscopy. The characteristic features of apoptosis like cell shrinkage, nuclear fragmentation, chromatin condensation and chromosomal DNA fragmentation were seen (Figure 5aiv ).
TUNEL assay is a standard method to confirm the presence of apoptosis in the cells and the same has been performed for all the groups, that is, normal, control and TFO-1-treated test groups. Figure 5aix-x shows the normal and the control groups liver cells with low amount of apoptotic bodies. Significant increase in the number of fragmented nuclei was observed in the test I group which further increased in test II group (Figure 5axi-xii) . Figure 5b shows the apoptotic indices calculated for all these above-described groups. Figure 5av -viii shows the immunohistochemical analysis (IHC) of the rat livers from different treatment groups. The MET expression in normal rats was almost undetectable (immunoscore 0); however, strong cytoplasmic and membranous positivity of MET protein was found in the DEN-treated samples of liver tumor (immunoscore þ 7). Tumor samples of TFO-1-treated test group I showed a moderate amount of immune-reactivity for MET (immunoscore þ 4). Test group II showed very few faint and focal MET-positive cells (immunoscore þ 2). Western blotting was performed for the same liver samples and is shown in Figure 5c and the fold change in the intensities is given in Figure 5d . Normal rat livers have moderate amount of MET expression which Circular dichroic spectroscopy CD is one of the simplest yet confirmatory techniques to determine the conformation of different forms of DNA like B-DNA, A-DNA and Z-DNA and other unusual DNA structural elements like hairpins, 32 triplex 28 and quadruplex. Therefore, CD was exploited to analyze the structural aspects of the DNA triplex formation. Figure 6a shows the CD spectra of duplex DNA-1, TFO-1 and of the mixture of duplex and TFO-1. The spectrum of duplex corresponds to the usual B-DNA with one positive ellipticity at 270 nm and two negative ellipticities at 242 and 216 nm. The CD spectrum of complex has additive effect of both duplex and TFO-1. Upon complexation, shift in the positive peak toward 260 nm, decrease in the negative ellipticity of 216 nm and increase in the 242 nm peak was observed. Since the CD spectra of the mixture differ substantially from that of the duplex and the third strand, temperature-induced changes in the CD spectra of the complex were monitored which represents the two transitions in the melting profile (Figure 6b ). First transition covers relatively small portion of the melting and centered around 47 1C, which corresponds to the dissociation of third strand while second transition is centered around 69 1C. The second transition is accompanied by a large ellipticity change and corresponds to dissociation of the duplex to single strand. CD spectroscopy confirms the presence of a DNA triple helical structure in the solution. Gel retardation assay Figure 7 shows the autoradiogram of GRA of 50 nM duplex, DNA-1 (lane 1) and mixtures of DNA-1 and TFO-1 in different mole ratios 2:1 (lane 2), 1:1 (lane 3) and 1:2 (lane 4). Gel result shows two bands, one the faster moving (lower band) corresponding to the DNA-1 and the retarded one (upper band) which corresponding to the DNA triplex. It is evident that as the TFO-1 ratio in the mixture is increased, the intensity of the DNA triplex band is increased which clearly proposes the triplex formation (lanes 3 and 4, Figure 7) . Simultaneously, the band intensity corresponding to DNA-1 gets diminished and later disappears, as the DNA triplex formation is maximum.
Expression of MET protein
Discussion
The hepatocyte growth factor/MET pathway is one of the most frequently deregulated pathways in human cancers, which activate several downstream pathways including RAS-MAPK (mitogen-activated protein kinase), PI3K (phosphotidylinositol 3 kinase)-AKT, STATs (signal transducer and activator of transcription), PLCg (phospholipase Cg) and c-Src. The activated MET kinase elicits different cellular responses by triggering these distinct pathways for example activation of RAS-MAPK pathway is mainly required for oncogenic transformation and cell proliferation, while the PI3K-AKT pathway primarily regulates both cell survival and motility. In addition, the recruitment of the protein phosphatase SHP2 (a Src homology 2-containing tyrosine phosphatase) by Gab1 is essential for branching morphogenesis. Therefore, phosphorylation profiles of multiple kinases shed ample light on our understanding of how cells recognize and respond to changes in their environment. Present results of phospho-array of HepG2 cell line after treatment with TFO-1 reveal loss of phosphorylation status of molecules ERK, MEK, AKT, Src, FAK, MSK and p38a. This clearly indicate the decreased activity of signaling pathways leading to proliferation inhibition. A similar observation of association of MET knockdown and decreased levels of phosphorylation of intracellular signaling molecules has been reported in lung cancer cell lines. 33 MET also has dual role with having antiapoptotic and pro-apoptotic properties and is involved in the differential regulation of the survival/apoptosis balance. There are studies which have shown the survival responses induced by hepatocyte growth factor/scatter factor were correlated with an increased expression of the antiapoptotic Bcl-xl and Bcl-2 proteins, which inhibit mitochondrial-dependent apoptosis. 34 In the view of the present results, the antiproliferative and apoptotic effect of TFO-1 can be suggested, based on the hyperphosphorylation of p53, Chk-2, the DNA damage indicators, the increased activity of Bax and decreased levels of Bcl-xl. Overexpression of p53 in HCC has been shown to induce apoptosis 35 and diminish the growth of tumor cells. 36 It may be recalled that the TTS-1 is located within positive regulatory element and contains the Sp1 binding site (GGCGGG). Sp1 is an essential transcription factor and any mutation in Sp1 binding site leads to drastic reduction in c-met transcription. 37 Therefore, it is obvious that binding of TFO-1 to TTS-1 is a primary cause for the observed inhibition of MET expression. TFO-2 could not generate any transcription inhibition as the targeted region TTS-2 is away from the transcription start site. Similarly, TFO-3 which is a non-specific sequence containing five mismatch base pairs (of TFO-1) could not again influenced the MET expression. These two findings further strongly support the sequence-specific antiproliferative effect of TFO-1 on c-met. However, a small insignificant inhibitory effect shown by TFO-2 and TFO-3 could be a possibility of exposure of cells to high concentrations of phosphorothioated oligonucleotides. As the inhibition of MET by TFO-1 is primarily due to the triple helical DNA, it was important to confirm the formation and stability of DNA triplex between the TFO-1 and TTS-1 and the same was performed by CD spectroscopy and GRA. Differential mobilities of DNA-1 duplex alone and in the presence of the TFO-1 clearly suggest DNA triplex formation ( Figure 7) .
DNA triplex-based antigene strategy provide additional advantage over other strategies, for example, small molecule kinase inhibitors, antibodies or decoy molecules are non-specific in nature while antisense stratgey can block mRNA translation but does not prevent the corresponding gene from being transcribed resulting in repopulating the RNA pool. In contrast, DNA triplex formation prevents gene transcription in a long-lasting way and specificially targeting overexpressed c-met oncogene without effecting the tumor micro-enviornment.
Further, for a more complete assessment, it is mandatory to use a comprehensive experimental model that mimics, as completely as possible, a large variety of pathological changes in humans. Therefore, the effect of TFO-1 was also assessed on the DEN induced HCC in rats as DEN causes liver lesions which closely mimic the different types of benign and malignant tumors in humans.
Our laboratory has demonstrated the role of MRI in the extent of tumor invasion in skin tumor previously. 38 In the present study, MRI was used as the first step to monitor the development and the dynamic growth of the liver tumors non-invasively and non-destructively. MR image of the normal rat shows homogeneous appearance of liver lobules (encircled) as shown in Figure 4ai , while liver tumor in control rat appears as hyperintense nodules in the T2-weighted images (Figure 4aiv ). It may be mentioned here that MRI is based on the differences in the environment of protons within and surrounding the tissue. The intensity of the tumor was found to be further increased with the tumor progression. Neoplasms have more free water than benign tissues and thus have longer relaxation times with progression of tumors; 39 therefore, tumor appears hyperintense in imaging. In TFO-1-treated groups, tumor intensity was less that may be due to the lesser cell mass accumulation. Tumor inhibition, apparently, is a result of decreased cellular proliferation and induction of cellular apoptosis as increased number of DNA frangmentation was observed in TUNEL assay.
It is interesting to see that TFO-1 cause downregulation of MET by B50% in both in vitro and in vivo. From this observation, it can be said that TFO-1 has high anticancer property.
The western blot results show almost 50% downregulation in the protein expression after 5 weeks TFO treatment, which seems to be sufficient to check the tumor growth as the reduction in tumor growth is significantly higher at this stage. It has been reported earlier that even 30% downregulation in MET stopped the tumor growth in nude mice as reported by Herynk et al. 40 This can be understood by the phenomenon of 'Oncogene Addiction'. As the sustained activity of a particular oncogene has found to be required for maintenance of tumors and attenuation of pro-survival signals in oncogene-dependent cells contribute to cell death following acute oncogene inactivation. 41, 42 The present study suggests that the apoptotic response to MET inhibition by TFO-1 reflects the cellular 'addiction' for MET. Oncogene inactivation leads to a transient imbalance in survival and apoptotic signals because survival signals are relatively short-lived in comparison with the apoptotic signals.
However, there are at least three possible results when the oncogenes are inactivated: first, malignant cells might differentiate into normal cells; second, their inactivation leads to proliferative arrest; and finally, tumor cells undergo apoptosis. The in vitro and in vivo experiments in the present study show that proliferation of HCC cells was significantly inhibited after knockdown of c-met by TFO-1 followed by apoptosis. Therefore, the present study establish the role of TFO-1 as a potential tumor suppressor agent. MET in the intial stages of invasion and metastasis 43, 44 and to sustain the metastasis 20 has been very well established in different experimental systems, suggesting that MET targeting could be fruitful therapeutic approach.
From the present results, we conclude that c-metspecific DNA triplex-based therapeutic approach is a promising tool to modulate gene expression and for the inhibition of cancer cell proliferation. TTS in the genome is either directly important for gene functionality or they act as spacing fragment to help the correct positioning of transcription factors. Therefore, this strategy can be useful to target a number of oncogenes. . We wish to thank Professor Sudha Bhattacharya, Dean, School of Environmental Sciences, Jawaharlal Nehru University, India for providing us g-32 P [ATP] and Professor Shyamal K Goswami, School of Life Sciences, Jawaharlal Nehru University, India for allowing us to carry out the gel retardation assay using radioactive material.
